Physician profile
Daniel G Collins
NPI 1588003818
$2,761.02
in general payments reported to CMS, 2019-2025
11 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $245 · 2021: $105 · 2022: $714 · 2023: $155 · 2024: $965 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $812 · Food and Beverage: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $812.44 |
| Food and Beverage | $518.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,083.02 | 2019-2025 | Embold Fibered, Eluvia, Therasphere Y90 Glass Microspheres 10 Gbq |
| Histosonics, INC. | $928.42 | 2024 | |
| Medtronic Vascular, INC. | $193.00 | 2019 | |
| Sirtex Medical INC | $147.91 | 2025 | Sir-Spheres Microspheres |
| Penumbra, INC. | $143.93 | 2020 | |
| Bard Peripheral Vascular, INC. | $124.94 | 2019-2020 | |
| Argon Medical Devices, INC. | $50.47 | 2023 | Cleaner |
| Janssen Pharmaceuticals, INC | $34.78 | 2023 | Xarelto |
| Haemonetics Corporation | $21.68 | 2025 | Teg6s Hemostasis System |
| Abbott Laboratories | $17.19 | 2019 | |
| Angiodynamics, INC. | $15.68 | 2023 | Micro Access |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.